{
    "paper_id": "0a4765a3e66581e2ab935f906e10bd96cc31c660",
    "metadata": {
        "title": "Antibacterial consumption in the context of COVID-19 in Pakistan: an analysis of national Short Title: Antibacterial consumption COVID-19 Pakistan Methods: We used IQVIA pharmaceutical sales volume data to analyze antibiotic consumption for",
        "authors": [
            {
                "first": "Ebiowei",
                "middle": [],
                "last": "Samuel",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "F",
                "middle": [],
                "last": "Orubu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "settlement": "Boston"
                    }
                },
                "email": "sforubu@bu.eduesfo"
            },
            {
                "first": "Albert",
                "middle": [],
                "last": "Figueras",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Carly",
                "middle": [],
                "last": "Ching",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "settlement": "Boston"
                    }
                },
                "email": ""
            },
            {
                "first": "Ahsan",
                "middle": [
                    "M"
                ],
                "last": "Fuzail",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "settlement": "Boston"
                    }
                },
                "email": ""
            },
            {
                "first": "Veronika",
                "middle": [
                    "J"
                ],
                "last": "Wirtz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Muhammad",
                "middle": [
                    "H"
                ],
                "last": "Zaman",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "settlement": "Boston"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Analysis: Data analysis was performed at the ATC level 3 (therapeutic groups) using two measures 89 of AbC: total consumption and consumption pattern. AbC was analysed as Defined Daily Doses 90 (DDD) per 1000 population per day, or DID (14) . For this comparative analysis, we used the 91 estimated population for 2019 of 216565318 and factored in a 2.1% growth to give the population 92 for 2020 as 221113190 (15).",
            "cite_spans": [
                {
                    "start": 236,
                    "end": 240,
                    "text": "(14)",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "93"
        },
        {
            "text": "The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244657 doi: medRxiv preprint where monthly sale amount = (Substance dosage form strength (mg/g) x unit pack-size x units 96 sold); and unit pack-size is the number of doses, or standard units, per pack. One standard unit was 97 a tablet, capsule, vial or ampoule. For oral suspensions or syrups meant for use in children, the 98 standard unit was 5 ml (17). For example, the unit pack-size for an oral liquid substance presented 99 as a 60 ml bottle was 60/5, or 12 standard units. With drops, the standard unit was adopted as 1. 123 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "93"
        },
        {
            "text": "The copyright holder for this preprint this version posted December 7, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244657 doi: medRxiv preprint compared to 42% of sales and 1.20 DID, in March 2019. Within \"others\" the rise was driven by 139 increase in the consumption of sulfamethoxazole-trimethoprim. coupled with COVID-19 related decrease in outpatient attendance in hospitals (18, 19) .",
            "cite_spans": [
                {
                    "start": 381,
                    "end": 385,
                    "text": "(18,",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 386,
                    "end": 389,
                    "text": "19)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "In contrast, the rise in the consumption of macrolides in March, and, in April 2020, of \"others\" 151 antibiotics, may have been a result of stock-piling by medicine outlets or clients of azithromycin, 152 following its social-media promotion, alongside chloroquine and hydroxychloroquine, as a 153 preventive or treatment for COVID-19. While \"others\" also rose, this increase was smaller, being 154 about three orders of magnitude lower. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "150"
        },
        {
            "text": "The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244657 doi: medRxiv preprint safety/toolkit_sources/en/ 219 13. Rieth M. IQVIA Quality Assurance. :137.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "150"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "220"
        },
        {
            "text": "The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244657 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "220"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "COVID-19 outbreak: current scenario of 201",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Waris",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "K"
                    ],
                    "last": "Atta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ali",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Asmat",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Baset",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "New Microbes New Infect",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Pakistan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "35",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Johns Hopkins Coronavirus Resource Center",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Pakistan confirms first two cases of coronavirus, govt says 206 \"no need to panic",
            "authors": [
                {
                    "first": "|",
                    "middle": [],
                    "last": "Siddiqui Ia| D Com",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Sas| N",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COVID-19 pandemic",
            "authors": [],
            "year": 2020,
            "venue": "J Pharm Policy Pract",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Lockdown Ended a Month Ago. Now Hospital Signs Read 'Full",
            "authors": [
                {
                    "first": "&apos;",
                    "middle": [],
                    "last": "Pakistan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "WHO | 7. Sources of Drug Utilization Data",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "World Health Organization. WHO report on surveillance of antibiotic consumption: 2016-221 2018 early implementation",
            "authors": [],
            "year": 2018,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Methods to analyse medicine utilization and expenditure to support pharmaceutical 227 policy implementation",
            "authors": [
                {
                    "first": "|",
                    "middle": [],
                    "last": "Pakistan",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Data",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Global sales of oral antibiotics 230 formulated for children. Bull World Health Organ",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bielicki",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hsia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sharland",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "98",
            "issn": "",
            "pages": "458--66",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Pakistan's consumer sector earnings dip 26% in 2019",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Recent increase in drug prices capped at 75pc",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Junaidi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Rapidly managing pneumonia in older people during a pandemic",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "for the treatment of tuberculosis. The extracted dataset contained 77 antibiotics available as 4648 81 products (tablets, capsules, injections/infusions, suspensions/oral powders for suspension and oral 82 drops of different dosage form strengths).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "IQVIA dataset was reclassified into current (2019) ATC codes, and based on a preliminary 84 analysis of sale volumes, recategorized into six therapeutic groups: (I) J01A, tetracyclines, (II) 85 J01C, beta-lactams, penicillins (III) J01D, other beta-lactams, (IV) J01F, macrolides, (V) J01M, 86 quinolones, and (VI) \"others\", consisting of eight sub-groups or individual antibiotics not already 87 classified.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Thus, a pediatric dropper of 10 ml volume had a unit pack-size of 10. Monthly DIDs were then 101 aggregated by therapeutic group.102Total AbC per year was calculated using the formula above by substituting two terms, namely the 103 'monthly sale amount' with the 'total monthly sales for all four months' and the 'days in the month'104 with a time period of 121 for 2020 and 120 for 2019. To analyse temporal changes, we used a 105 \"year-on-year\" change (%) metric comparing the \"yearly\" DID for the first four months of 2020 106 to 2019. 107 AbC pattern was described in terms of proportions (%) of total AbC by therapeutic group for each 108 month. To analyse differences in consumption pattern we used a month-on-month change (%) Table 1. Antibiotic consumption for January-April of 2019 and 2020 in Pakistan expressed 120 as defined daily doses per 1000 inhabitants per day (DID) and month-on-month changes in 121 consumption (see Methods). 122 Therapeutic group Antimicrobial consumption (DDD per 1000 population per day, or DID)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "people consumed the macrolide class per day in the month of March in 2020 127 compared to 2019; while \"others\" rose to 1.06 DID in April 2020 from 0.94 DID in 2019 Antibiotic consumption patterns for January-April of 2019 and 2020 in Pakistan.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "2020 consumption was lower for antibiotics for systemic use (ATC J01) during the study 133 period of January-April, except for macrolides which showed a rise for February and March 134 of 2020, and \"others\" with an increase in April 2020. 135 Within the macrolidesazithromycin, clarithromycin, clindamycin, erythromycin, lincomycin 136 and roxithromycinazithromycin was the most commonly-consumed. In March 2020, 137 azithromycin contributed 50% to macrolide sale volume with a related consumption of 1.70 DID,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "One of the characteristics of the present outbreak of the COVID-19 pandemic is the 141 general medical uncertainty due to the fact that both the agent (SARS-CoV2) and the disease were 142 completely unknown six months before this study was conducted. Within this context of 143 uncertainty, lack of sound evidence and an unprecedented amount of circulating information, to 144 analyse the consumption of a few antibiotics involved in this information overload is of interest 145 because of the impact of inappropriate consumption on the global AMR threat. 146 This analysis revealed a \"year-on-year\" drop in total AbC in the first four months of 2020. This 147 may have due to an economic crisis with currency devaluation and price increases that started in 148 2018 and supply chain disruptions from these and border closures with China and India in 2019,149",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "Within the context of COVID-19, three classes of antibacterials are of interest: macrolides,156    quinolones, and aminoglycosides. In addition to social media promotion, several early guidelines1. Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in 184 the COVID-19 pandemic. Bull World Health Organ [Internet]. 2020 Jul 1 [cited 2020 Jul 185 2];98(7):442-442A. Available from: http://www.who.int/entity/bulletin/volumes/98TM, Ming D, Ahmad R, Moore LSP, Holmes AH. Antimicrobial use, drug-188 resistant infections and COVID-19. Nat Rev Microbiol [Internet]. 2020 Jun 2 [cited 2020 189 Jul 5];1-2. Available from: https://www.nature.com/articles/s41579-020-0395-y 190 3. Eynde V, Jacques J. COVID-19: A Brief Overview of the Discovery Clinical Trial. 191 Pharmaceuticals [Internet]. 2020 Apr [cited 2020 Apr 20];13(4):65. Available from: 192 https://www.mdpi.com/1424-8247/13/4/65 193 4. \"Solidarity\" clinical trial for COVID-19 treatments [Internet]. [cited 2020 Jul 6]. Available 194 from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-195 on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments 196 5. Soto A. Nigeria Has Chloroquine Poisonings After Trump Praised Drug [Internet]. 197 Bloomberg.com. 2020 [cited 2020 Apr 21]. Available from: 198 https://www.bloomberg.com/news/articles/2020-03-21/nigeria-reports-chloroquine-199 poisonings-after-trump-praised-drug 200 .",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}